AMANDA LILLY: Open Payments
NPI 1003290206 · MANSFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 25 payments from 15 companies in 2025. Trend: 2023 $478 · 2024 $310 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Dexcom, Inc. | 2 | $33 |
| Indivior Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: CAPLYTA, ABILIFY ASIMTUFII, INGREZZA, REXULTI, XIFAXAN, Dexcom G6 Transmitter, ABILIFY MAINTENA, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
